Literature DB >> 22430922

Physicochemical performances of indomethacin in cholesteryl cetyl carbonate liquid crystal as a transdermal dosage.

Nunchanit Aeinleng1, Sarunyou Songkro, Kusumarn Noipha, Teerapol Srichana.   

Abstract

A transdermal formulation of indomethacin (IMC) was developed by incorporation into cholesteryl cetyl carbonate (CCC). The liquid crystalline phase properties of the IMC-CCC mixture were detected by polarized light microscopy and differential scanning calorimetry. A low drug loading was obtained (1-5 %) similar to that used in conventional topical IMC in a clinical setting. A controlled release of IMC was found over 12 h. A low amount of IMC in 1 % IMC-CCC permeated the stratum corneum. Further formulation development has been carried out by the addition of lauryl alcohol into 5 % IMC-CCC mixture it was found that the permeation of IMC was significantly improved to 45 % within 24 h.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430922      PMCID: PMC3364373          DOI: 10.1208/s12249-012-9768-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  21 in total

1.  FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms.

Authors:  Martin Siewert; Jennifer Dressman; Cynthia K Brown; Vinod P Shah
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  Spray-dried indomethacin-loaded polyester nanocapsules and nanospheres: development, stability evaluation and nanostructure models.

Authors:  Adriana Raffin Pohlmann; Valeria Weiss; Omar Mertins; Nádya Pesce da Silveira; Sílvia Stanisçuaski Guterres
Journal:  Eur J Pharm Sci       Date:  2002-09       Impact factor: 4.384

3.  Structure and drug release of lamellar liquid crystals containing glycerol.

Authors:  M Makai; E Csányi; Zs Németh; J Pálinkás; I Eros
Journal:  Int J Pharm       Date:  2003-04-30       Impact factor: 5.875

Review 4.  Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration.

Authors:  C C Müller-Goymann
Journal:  Eur J Pharm Biopharm       Date:  2004-09       Impact factor: 5.571

5.  Indomethacin-induced intestinal inflammation.

Authors:  W F Fang; A Broughton; E D Jacobson
Journal:  Am J Dig Dis       Date:  1977-09

6.  Physicochemical properties and antifungal activity of amphotericin B incorporated in cholesteryl carbonate esters.

Authors:  Rabkwan Chuealee; Timothy Scott Wiedmann; Teerapol Srichana
Journal:  J Pharm Sci       Date:  2010-11-24       Impact factor: 3.534

7.  Topography of prostaglandin H synthase. Antiinflammatory agents and the protease-sensitive arginine 253 region.

Authors:  R J Kulmacz
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

8.  In vitro peptide release from liquid crystalline buccal delivery systems.

Authors:  J Lee; I W Kellaway
Journal:  Int J Pharm       Date:  2000-02-15       Impact factor: 5.875

9.  Precision and reproducibility of temperature response of a thermo-responsive membrane embedded by binary liquid crystals for drug delivery.

Authors:  S Y Lin; C J Ho; M J Li
Journal:  J Control Release       Date:  2001-06-15       Impact factor: 9.776

10.  The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.

Authors:  Sunil Jambhekar; R Casella; T Maher
Journal:  Int J Pharm       Date:  2004-02-11       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.